Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Cutting-edge cancer treatments showcased at ESMO

October 18, 2010 Research and Development AstraZeneca, Boehringer, Cancer, Cancer Conference, Johnson & Johnson, Novartis, personalised medicine

The search for a ‘silver bullet’ against cancer has failed, for now, with the battle against the disease turning instead …
Feature

Sanofi signs translational research deal with Harvard

October 18, 2010 Research and Development Harvard, Sanofi-Aventis, academia, translational

Sanofi-Aventis is to collaborate on translational biomedical research with Harvard University in therapy areas such as cancer, diabetes and inflammation. …
News

Trial shows long-term benefits of Novartis’ Aclasta

October 18, 2010 Research and Development, Sales and Marketing Novartis, aclasta, osteoporosis

Novartis has published new data at the annual meeting of the American Society for Bone and Mineral Research in Toronto …
News

Roche investing $180m on US diagnostics facilities

October 18, 2010 Research and Development Diagnostics, Roche, Ventana, personalised medicine

Swiss drugmaker Roche is planning to invest $180 million and boost staff at its diagnostics subsidiary Ventana Medical Systems, as …
News
Images of a normal brain and an Alzheimer's brain

Alzheimer’s disease

October 16, 2010 Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, Elan, J&J, JJ, Pfizer, lilly, pharmaceutical

In 1906 a psychiatrist working in a Frankfurt asylum became fascinated by the unnamed illness suffered by one of his …
Feature

Contract research news in brief

October 15, 2010 Research and Development Clinipace, Covance, PPD, Quintiles, Synexus, cellectis

Our latest crop of contract research news includes updates from Clinipace, PPD, Cellectis bioresearch, Covance, Quintiles and Synexus. US contract …
News

Celgene completes Abraxis takeover

October 15, 2010 Research and Development, Sales and Marketing Abraxane, Abraxis, Celgene, mergers and acquisitions, oncology

Celgene has completed its acquisition of Abraxis BioScience for cash and stock totalling $2.9 billion. The takeover gives the cancer …
News

Researchers unearth Pfizer’s buried data

October 14, 2010 Research and Development Ben Goldacre, Pfizer, publication, reboxetine, trial data

Researchers from Germany’s cost-effectiveness body IQWiG have unearthed a mountain of unpublished data from trials of Pfizer’s reboxetine that show …
News

Merck Serono eyes ‘Nanobody’ potential in rheumatology

October 14, 2010 Research and Development Ablynx, Merck Serono

Merck Serono has expanded its research with Ablynx and will co-develop ‘Nanobodies’ from the Belgian biotech against an inflammatory disease …
News

UK invests £50m in targeted research

October 13, 2010 Research and Development BIA, clinical research, genomics, personalised medicine, targeting

The government is to put more than £50 million of funding into a new initiative to produce more targeted research …
News

Philip Vickers joins Shire

October 13, 2010 Research and Development Shire, appointment, research and development

Shire has appointed Philip Vickers as senior VP of research and development for its Human Genetic Therapies (HGT) business. He …
Appointment

Pharmsynthez boosts board

October 12, 2010 Manufacturing and Production, Research and Development Pharmsynthez, appointment, manufacturing and production, research and development

Moscow-based pharmaceutical company JSC Pharmsynthez has appointed Miroslav Ravic and Howard Fisher to its board as independent non-executive directors. Miroslav …
Appointment

UCB signs Parkinson’s research deal

October 12, 2010 Research and Development Parkinson's, Synosia Therapeutics, UCB, neurology

UCB has partnered with Synosia Therapeutics to develop two of the Swiss firm’s compounds for Parkinson’s disease.  Basel-based Synosia has …
News

Stem cell trial re-starts

October 12, 2010 Research and Development Geron, Stem cells, spinal injury

Geron Corporation has enrolled the first patient in its restarted clinical trial of human embryonic stem cells (hESC). The world’s …
News

Making the most of outsourcing and offshoring

October 12, 2010 Manufacturing and Production, Research and Development Kinapse, outsourcing

As the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …
Feature
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026